Prelude Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
|
|||||
|
2025
Q1 | $2.67M | Buy |
|
|||||
|
2024
Q4 | $2.9M | Sell |
|
|||||
|
2024
Q3 | $3.16M | Buy |
|
|||||
|
2024
Q2 | $2.77M | Sell |
|
|||||
|
2024
Q1 | $2.81M | Buy |
|
|||||
|
2023
Q4 | $204K | Sell |
|
|||||
|
2023
Q3 | $260K | Sell |
|
|||||
|
2023
Q2 | $497K | Buy |
|
|||||
|
2023
Q1 | $301K | Buy |
|
|||||
|
2022
Q4 | $169K | Buy |
|